GLP-1 recall: Mounjaro, Zepbound ingredient risk raised to second-highest level
A drug containing an ingredient also used in the popular weight-loss medications Zepbound and Mounjaro is being recalled due to manufacturing problems. The company that makes it received a warning from the FDA in December 2025 about deficiencies in how it produces sterile drug products. The safety concern has been raised to the second-highest risk level.
6 across the spectrum. Choose a side on the bar to jump to it.
National story. 6 articles from 6 sources. Updated 5d ago.
Left
3 sourcesA GLP-1 drug that shares an ingredient with Zepbound and Mounjaro is being recalled
Center
2 sourcesSame wire story as other sides. No original Center take here.
Right
1 sourceSame wire story as other sides. No original Right take here.
GLP-1 recall: Mounjaro, Zepbound ingredient risk raised to second-highest level
The bigger story
This story is one of several related ones. Here's where it sits.